Adial Pharmaceuticals, Inc. Share Price & Technical Analysis
ADIL · $2.08 (-9.57%)
Healthcare / Biotechnology
$2.08
-9.57%
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pa…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
40% return in May, -15% avg return in past 3 year May month.
-70% return in 2026, -56% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | -55% | -28% | -17% | 40% | – | – | – | – | – | – | – | -70% |
| 25 | -17% | -6% | -17% | 11% | -2% | -56% | 57% | -3% | -10% | -4% | -11% | -31% | -90% |
| 24 | -39% | 69% | -58% | 32% | -17% | -20% | -8% | -6% | 1% | -2% | 0% | 1% | -46% |
| 23 | 129% | -15% | -24% | -3% | -28% | -19% | 45% | -47% | -35% | -33% | 9% | -11% | -33% |
| 22 | -21% | -5% | -4% | -28% | -11% | 6% | -51% | -17% | -35% | -14% | -10% | -19% | -209% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Strong
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.96M
P/E ratio
—
52W high
$19.00
52W low
$1.31
Volume
1,44,683
Beta
1.27
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Adial Pharmaceuticals, Inc. share price today?
- Adial Pharmaceuticals, Inc. (ADIL) last traded around $2.08 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ADIL have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ADIL. Download the app for real-time alerts.
- How can I analyze Adial Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.